Search research articles
Contact Us
Filters
Showing results (1-10 of 32) with videos related to
Page
of 4
Sort By:
ACS Applied Materials & Interfaces
|
January 19, 2022
Liquid Polymer/Metallic Salt-Based Stretchable Strain Sensor to Evaluate Fruit Growth
Hyun Jae Lee, Robin Joyce, Junghoon Lee
Cancer Biotherapy & Radiopharmaceuticals
|
May 19, 2006
Extravazation of therapeutic yttrium-90-ibritumomab tiuxetan (zevalin): a case report
Gethin Williams, Matthew R Palmer, J Anthony Parker, et al.
Angiology
|
October 3, 2008
Significance of close surveillance of patients with peripheral arterial disease
Robin Joyce Barrows, Ulrike Krumsdorf, Alexandra Zankl, et al.
Abdominal Imaging
|
January 21, 2014
Pancreatic atrophy in patients with chronic graft-versus-host disease
Olga Rachel Brook, Charles P Mullan, Mishal Mendiratta-Lala, et al.
Blood Advances
|
May 23, 2020
Dose-adjusted enoxaparin thromboprophylaxis in hospitalized cancer patients: a randomized, double-blinded multicenter phase 2 trial
Jeffrey I Zwicker, Joanna Roopkumar, Maneka Puligandla, et al.
Clinical Lymphoma
|
September 30, 2004
Yttrium 90-labeled ibritumomab tiuxetan radioimmunotherapy produces high response rates and durable remissions in patients with previously treated B-cell lymphoma
Leo I Gordon, Thomas Witzig, Arturo Molina, et al.
British Journal of Haematology
|
July 27, 2022
Complete responses to odronextamab in two patients with diffuse large B-cell lymphoma refractory to chimeric antigen receptor T-cell therapy
Matt Weinstock, Pavania Elavalakanar, Susan Bright, et al.
American Journal of Hematology
|
August 19, 2014
Sequential infusion of donor-derived dendritic cells with donor lymphocyte infusion for relapsed hematologic cancers after allogeneic hematopoietic stem cell transplantation
Vincent T Ho, Haesook T Kim, Grace Kao, et al.
The Lancet. Haematology
|
October 11, 2021
Venetoclax with dose-adjusted EPOCH-R as initial therapy for patients with aggressive B-cell lymphoma: a single-arm, multicentre, phase 1 study
Sarah C Rutherford, Jeremy S Abramson, Nancy L Bartlett, et al.
Blood
|
June 13, 2019
Brentuximab vedotin, doxorubicin, vinblastine, and dacarbazine for nonbulky limited-stage classical Hodgkin lymphoma
Jeremy S Abramson, Jon E Arnason, Ann S LaCasce, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 32) with videos related to
Sort By:
Page
of 4
ACS Applied Materials & Interfaces
|
January 19, 2022
Liquid Polymer/Metallic Salt-Based Stretchable Strain Sensor to Evaluate Fruit Growth
Hyun Jae Lee, Robin Joyce, Junghoon Lee
Cancer Biotherapy & Radiopharmaceuticals
|
May 19, 2006
Extravazation of therapeutic yttrium-90-ibritumomab tiuxetan (zevalin): a case report
Gethin Williams, Matthew R Palmer, J Anthony Parker, et al.
Angiology
|
October 3, 2008
Significance of close surveillance of patients with peripheral arterial disease
Robin Joyce Barrows, Ulrike Krumsdorf, Alexandra Zankl, et al.
Abdominal Imaging
|
January 21, 2014
Pancreatic atrophy in patients with chronic graft-versus-host disease
Olga Rachel Brook, Charles P Mullan, Mishal Mendiratta-Lala, et al.
Blood Advances
|
May 23, 2020
Dose-adjusted enoxaparin thromboprophylaxis in hospitalized cancer patients: a randomized, double-blinded multicenter phase 2 trial
Jeffrey I Zwicker, Joanna Roopkumar, Maneka Puligandla, et al.
Clinical Lymphoma
|
September 30, 2004
Yttrium 90-labeled ibritumomab tiuxetan radioimmunotherapy produces high response rates and durable remissions in patients with previously treated B-cell lymphoma
Leo I Gordon, Thomas Witzig, Arturo Molina, et al.
British Journal of Haematology
|
July 27, 2022
Complete responses to odronextamab in two patients with diffuse large B-cell lymphoma refractory to chimeric antigen receptor T-cell therapy
Matt Weinstock, Pavania Elavalakanar, Susan Bright, et al.
American Journal of Hematology
|
August 19, 2014
Sequential infusion of donor-derived dendritic cells with donor lymphocyte infusion for relapsed hematologic cancers after allogeneic hematopoietic stem cell transplantation
Vincent T Ho, Haesook T Kim, Grace Kao, et al.
The Lancet. Haematology
|
October 11, 2021
Venetoclax with dose-adjusted EPOCH-R as initial therapy for patients with aggressive B-cell lymphoma: a single-arm, multicentre, phase 1 study
Sarah C Rutherford, Jeremy S Abramson, Nancy L Bartlett, et al.
Blood
|
June 13, 2019
Brentuximab vedotin, doxorubicin, vinblastine, and dacarbazine for nonbulky limited-stage classical Hodgkin lymphoma
Jeremy S Abramson, Jon E Arnason, Ann S LaCasce, et al.
Page
of 4